Sabra Healthcare REIT Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.7% | 48.2% | 31.7% | 45.5% | 54.9% | 43.9% | 43.7% | 42.8% | 52.6% | 41.3% | 44.4% | 36.4% | 43.2% | |
| 26.9% | 26.2% | 25.7% | 23.7% | 24.0% | 23.2% | 23.7% | 23.0% | 25.5% | 24.3% | 24.0% | 23.9% | 24.4% | |
| 1.4% | 1.5% | 1.5% | 0.8% | 1.5% | 1.4% | 1.5% | 1.4% | 1.5% | 1.4% | 1.4% | 1.7% | 1.5% | |
| 4.1% | 3.0% | -16.6% | -1.2% | 16.7% | -3.7% | -4.1% | -3.3% | 4.3% | -2.0% | 0.3% | -5.6% | -1.0% | |
| 50.1% | 3.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 10.7% | 2.9% | |
| 37.2% | -37.8% | -7.9% | -32.5% | -32.0% | 10.2% | -9.0% | -23.9% | -105.2% | -55.0% | -47.4% | 36.7% | -39.0% | |
| 43.1% | 42.5% | 41.6% | 39.4% | 39.5% | 38.9% | 38.9% | 37.7% | 37.9% | 35.3% | 34.1% | 32.1% | 34.7% | |
| 0.0% | -0.3% | -1.6% | 1.5% | – | – | -2.9% | – | – | – | -3.7% | 3.5% | – | |
| – | – | – | – | 12.0% | -24.5% | -13.3% | 41.5% | 62.7% | -30.9% | 61.9% | -15.9% | 17.8% | |
| -84.7% | -5.7% | -12.1% | -26.3% | -7.8% | -55.4% | -55.2% | 19.4% | 108.5% | -47.6% | 23.5% | -24.3% | 11.6% | |
| 4.0% | 4.8% | 11.5% | -13.4% | 15.0% | -1.4% | -20.4% | 38.5% | 55.7% | -61.1% | 20.4% | 48.7% | 15.9% | |
| 51.7% | 48.2% | 31.7% | 45.5% | 54.9% | 43.9% | 43.7% | 42.8% | 52.6% | 41.3% | 44.4% | 25.7% | 40.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.